A 5-YEAR EXPERIENCE OF LIPIODOLIZATION - SELECTIVE REGIONAL CHEMOTHERAPY FOR 200 PATIENTS WITH HEPATOCELLULAR-CARCINOMA

被引：202

作者：

KANEMATSU, T ^{[1
]}

FURUTA, T ^{[1
]}

TAKENAKA, K ^{[1
]}

MATSUMATA, T ^{[1
]}

YOSHIDA, Y ^{[1
]}

NISHIZAKI, T ^{[1
]}

HASUO, K ^{[1
]}

SUGIMACHI, K ^{[1
]}

机构：

[1] KYUSHU UNIV,FAC MED,DEPT RADIOL,FUKUOKA 812,JAPAN

来源：

HEPATOLOGY | 1989年 / 10卷 / 01期

关键词：

D O I：

10.1002/hep.1840100119

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：98 / 102

页数：5

共 21 条

[1] SELECTIVE EFFECT OF DOXORUBICIN SUSPENDED IN LIPIODOL ON VX2 CARCINOMA IN RABBITS [J].

FURUTA, T ;

KANEMATSU, T ;

KAKIZOE, S ;

SUGIMACHI, K .

JOURNAL OF SURGICAL ONCOLOGY, 1988, 39 (04) :229-234

[2]

INOKUCHI K, 1979, ANN CHIR GYNAECOL FE, V68, P94

[3] SELECTIVE EFFECTS OF LIPIODOLIZED ANTITUMOR AGENTS [J].

KANEMATSU, T ;

INOKUCHI, K ;

SUGIMACHI, K ;

FURUTA, T ;

SONODA, T ;

TAMURA, S ;

HASUO, K .

JOURNAL OF SURGICAL ONCOLOGY, 1984, 25 (03) :218-226

[4] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].

KAPLAN, EL ;

MEIER, P .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481

[5] EFFECT OF ARTERIAL ADMINISTRATION OF HIGH-MOLECULAR-WEIGHT ANTI-CANCER AGENT SMANCS WITH LIPID LYMPHOGRAPHIC AGENT ON HEPATOMA - A PRELIMINARY-REPORT [J].

KONNO, T ;

MAEDA, H ;

IWAI, K ;

TASHIRO, S ;

MAKI, S ;

MORINAGA, T ;

MOCHINAGA, M ;

HIRAOKA, T ;

YOKOYAMA, I .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (08) :1053-&

[6]

KONNO T, 1984, CANCER, V54, P2367, DOI 10.1002/1097-0142(19841201)54:11<2367::AID-CNCR2820541111>3.0.CO

[7]

2-F

[8]

LIM RC, 1984, ARCH SURG-CHICAGO, V119, P637

[9]

NAKASHIMA T, 1987, HEPATOCELLULAR CARCI, P105

[10]

OGITA S, 1987, CANCER, V60, P2886, DOI 10.1002/1097-0142(19871215)60:12<2886::AID-CNCR2820601206>3.0.CO

← 1 2 3 →